2024
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
Kim M, Lee H, Lee S, Kwon R, Rhee S, Lee J, Koyanagi A, Smith L, Fond G, Boyer L, Lee J, Rahmati M, Shin J, Min C, Shin J, Yon D. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study. Annals Of Internal Medicine 2024, 177: 291-302. PMID: 38437702, DOI: 10.7326/m23-1831.Peer-Reviewed Original ResearchConceptsAutoimmune inflammatory rheumatic diseasesUninfected control patientsInfluenza infectionControl patientsSARS-CoV-2 infectionHistory of COVID-19Acute COVID-19Uninfected patientsSeverity of acute COVID-19Severe acute COVID-19Associated with increased riskSARS-CoV-2Follow-up periodInflammatory rheumatic diseasesClaims-based databaseLong-term riskMatched index datePropensity score matchingJapanese patientsIndex dateMatched patientsCohort studyJapanese cohortPrimary outcomeIncreased risk
2004
Clinical Risk Groups (CRGs)
Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, Gay JC. Clinical Risk Groups (CRGs). Medical Care 2004, 42: 81-90. PMID: 14713742, DOI: 10.1097/01.mlr.0000102367.93252.70.Peer-Reviewed Original ResearchMeSH KeywordsCapitation FeeChronic DiseaseConcurrent ReviewDiagnosis-Related GroupsForecastingHealth Services Needs and DemandHealth Services ResearchHumansInsurance Claim ReviewInsurance, HealthMedicaidMedicareProgram DevelopmentReimbursement MechanismsRisk AdjustmentSeverity of Illness IndexUnited States
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply